Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for LETAIRIS Letairis is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting…
SPIRIVA (tiotropium bromide) Boehringer ingelheim Patent: RE39820 Expiration: Jul 30, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for RAVICTI Ravicti is a drug marketed by Horizon Theraps Inc and is included in one NDA. It is available from one supplier. There are eight…
Annual Drug Patent Expirations for VIADUR Viadur is a drug marketed by Ortho Mcneil Janssen and is included in one NDA. There are two patents protecting this drug. Drug patent…
Annual Drug Patent Expirations for XERESE Xerese is a drug marketed by Valeant Bermuda and is included in one NDA. It is available from one supplier. There are two patents…
Annual Drug Patent Expirations for SUPRENZA Suprenza is a drug marketed by Citius Pharms and is included in one NDA. It is available from one supplier. There are two patents…
Annual Drug Patent Expirations for HEPSERA Hepsera is a drug marketed by Gilead and is included in one NDA. It is available from two suppliers. There is one patent protecting…
Annual Drug Patent Expirations for VALTURNA Valturna is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. Drug patent litigation for…
Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are three patents protecting this drug. This drug has one…